"Mary Bridge Children's Hospital was founded in 1955 and is southwest Washington's only pediatric hospital. Located in Tacoma, Washington, the hospital offers a wide range of pediatric care and services, and is recognized for medical excellence and child-friendly care."

During the past decade, Mary Bridge Children's Hospital and Health Center conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 47 clinical trials were completed, i.e. on average, 57.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 19 clinical trials were completed. i.e. 105.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Bridge Children's Hospital and Health Center" #1 sponsor was "Children's Oncology Group" with 73 trials, followed by "National Cancer Institute (NCI)" with 49 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored and "SWOG Cancer Research Network" with 8 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Bridge Children's Hospital and Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 97 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Children's Oncology Group" with 4 trials as a collaborator, "American Academy of Pediatrics" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Mary Bridge Children's Hospital and Health Center" are "Acute Lymphoblastic Leukemia" (10 trials), "Neuroblastoma" (8 trials), "Malignant Solid Neoplasm" (7 trials), "Recurrent Neuroblastoma" (7 trials) and "Recurrent Osteosarcoma" (7 trials). Many other conditions were trialed in "Mary Bridge Children's Hospital and Health Center" in a lesser frequency.

Most popular intervention types in "Mary Bridge Children's Hospital and Health Center" are "Drug" (122 trials), "Other" (86 trials), "Biological" (66 trials), "Procedure" (60 trials) and "Radiation" (42 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "Cyclophosphamide" (32 trials), "Vincristine Sulfate" (31 trials), "Questionnaire Administration" (30 trials) and "Biospecimen Collection" (28 trials). Other intervention names were less common.

The vast majority of trials in "Mary Bridge Children's Hospital and Health Center" are 156 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mary Bridge Children's Hospital and Health Center". undefined are not yet recruiting, 46 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Mary Bridge Children's Hospital and Health Center, 3 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Bridge Children's Hospital and Health Center, 5 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Mary Bridge Children's Hospital and Health Center has several departments that took part in Clinical trials: "Mary Bridge Children's Health Center" - 11 trials, "Mary Bridge Children's Therapy Unit" - 2 trials, "Mary Bridge Children's Neurology" - 2 trials